Michael J. Iannotti
National Center for Advancing Translational Sciences, National Institutes of Health
Papers
2
Total Citations
75
H-Index
2
About
Michael J. Iannotti is a leading figure in the field of stem cell bioengineering, whose work is revolutionizing how human pluripotent stem cells are cultured and differentiated for therapeutic applications. His primary research focuses on the intersection of robotics, high-throughput biomanufacturing, and stem cell biology. Iannotti’s major contribution lies in pioneering automated, scalable systems that replace the highly variable and labor-intensive manual culture of human induced pluripotent stem cells (hiPSCs). By developing robotic platforms capable of maintaining optimal self-renewal and guiding functional differentiation, he has addressed a critical bottleneck in translating stem cell therapies from the lab to the clinic. His most influential work, a 2021 paper on robotic high-throughput biomanufacturing, has garnered 68 citations, underscoring its significance in the field. This achievement demonstrates his impact in creating reproducible, efficient manufacturing strategies essential for large-scale drug screening and regenerative medicine. Iannotti’s innovative approach promises to accelerate the development of consistent, high-quality cell products, marking a pivotal step toward making stem cell-based treatments a practical reality.
Research Focus
Key Achievements
Top Papers
- 1
- 2